GUJARAT THEMIS BIOSYN
Back to Cashflow Statement
|
GUJARAT THEMIS BIOSYN Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹26 Cr | ₹-8.59 Cr | ₹-13 Cr | ₹-14 Cr | ₹-5.16 Cr |
What is the latest Cash Flow from Financing Activities ratio of GUJARAT THEMIS BIOSYN ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹26 Cr |
| Mar2024 | ₹-8.59 Cr |
| Mar2023 | ₹-13 Cr |
| Mar2022 | ₹-14 Cr |
| Mar2021 | ₹-5.16 Cr |
How is Cash Flow from Financing Activities of GUJARAT THEMIS BIOSYN Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹26 Cr | Positive | |
| Mar2024 | ₹-8.59 Cr | Negative | |
| Mar2023 | ₹-13 Cr | Negative | |
| Mar2022 | ₹-14 Cr | Negative | |
| Mar2021 | ₹-5.16 Cr | - | |
Compare Cash Flow from Financing Activities of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹3,964.9 Cr | 1% | 44.6% | 32.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | 11.6% | 0.7% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,697.0 Cr | 2.3% | 8.5% | 8.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,859.0 Cr | 1.8% | -1.8% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,421.0 Cr | 0.5% | 3.2% | 13.3% | Stock Analytics | |
| CIPLA | ₹105,811.0 Cr | 1.2% | 5.4% | -13.7% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | 1% |
44.6% |
32.5% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses